Phibro Animal Health (PAHC) Reports In-Line Q3 EPS, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results
May 6, 2021 4:40 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced financial results for its third quarter and year-to-date period ended March 31, 2021.
Highlights for the March 31, 2021 quarter (compared to the quarter ended March 31, 2020)
Net sales of $212 million, an increase of $1 million, or less than 1% Net income of $12 million, a decrease of $1 million, or 10% Diluted EPS of $0.30, a decrease of $0.03, or 9% Adjusted EBITDA of $28 million, a decrease of $2 million, or 7% Adjusted Net Income of $14 million, a decrease of $2 million, or... More